Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

por Burcombe, R J, Makris, A, Richman, P I, Daley, F M, Noble, S, Pittam, M, Wright, D, Allen, S A, Dove, J, Wilson, G D
Publicado 2005

Case-mix fails to explain variation in mastectomy rates: management of screen-detected breast cancer in a UK region 1997–2003

por Caldon, L J M, Walters, S J, Reed, J A, Murphy, A, Worley, A, Reed, M W R
Publicado 2005

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progressio...

por Couvelard, A, O'Toole, D, Turley, H, Leek, R, Sauvanet, A, Degott, C, Ruszniewski, P, Belghiti, J, Harris, A L, Gatter, K, Pezzella, F
Publicado 2005

The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer

por Day, R S, Shackney, S E, Peters, W P
Publicado 2005

Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours

por Almstrup, K, Hoei-Hansen, C E, Nielsen, J E, Wirkner, U, Ansorge, W, Skakkebæk, N E, Rajpert-De Meyts, E, Leffers, H
Publicado 2005

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

por Awada, A, Hendlisz, A, Gil, T, Bartholomeus, S, Mano, M, de Valeriola, D, Strumberg, D, Brendel, E, Haase, C G, Schwartz, B, Piccart, M
Publicado 2005

Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin

por Dietze, A, Peng, Q, Selbo, P K, Kaalhus, O, Müller, C, Bown, S, Berg, K
Publicado 2005

Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients

por Corrie, P G, Shaw, J, Spanswick, V J, Sehmbi, R, Jonson, A, Mayer, A, Bulusu, R, Hartley, J A, Cree, I A
Publicado 2005

Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer

por Kuefer, R, Hofer, M D, Zorn, C S M, Engel, O, Volkmer, B G, Juarez-Brito, M A, Eggel, M, Gschwend, J E, Rubin, M A, Day, M L
Publicado 2005

The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor α

por Wada-Hiraike, O, Yano, T, Nei, T, Matsumoto, Y, Nagasaka, K, Takizawa, S, Oishi, H, Arimoto, T, Nakagawa, S, Yasugi, T, Kato, S, Taketani, Y
Publicado 2005

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer

por Leung, W K, To, K-F, Chu, E S H, Chan, M W Y, Bai, A H C, Ng, E K W, Chan, F K L, Sung, J J Y
Publicado 2005

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder

por Sak, S C, Barrett, J H, Paul, A B, Bishop, D T, Kiltie, A E
Publicado 2005

Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence

por Morris, C D, Rose, A, Curwen, J, Hughes, A M, Wilson, D J, Webb, D J
Publicado 2005

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients

por Tonini, G, Vincenzi, B, Santini, D, Scarpa, S, Vasaturo, T, Malacrino, C, Coppola, R, Magistrelli, P, Borzomati, D, Baldi, A, Antinori, A, Caricato, M, Nuzzo, G, Picciocchi, A
Publicado 2005

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma

por Ord, J J, Streeter, E, Jones, A, Le Monnier, K, Cranston, D, Crew, J, Joel, S P, Rogers, M A, Banks, R E, Roberts, I S D, Harris, A L
Publicado 2005

Gene expression signatures for colorectal cancer microsatellite status and HNPCC

por Kruhøffer, M, Jensen, J L, Laiho, P, Dyrskjøt, L, Salovaara, R, Arango, D, Birkenkamp-Demtroder, K, Sørensen, F B, Christensen, L L, Buhl, L, Mecklin, J-P, Järvinen, H, Thykjaer, T, Wikman, F P, Bech-Knudsen, F, Juhola, M, Nupponen, N N, Laurberg, S, Andersen, C L, Aaltonen, L A, Ørntoft, T F
Publicado 2005

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer

por Milde-Langosch, K, Bamberger, A-M, Rieck, G, Grund, D, Hemminger, G, Müller, V, Löning, T
Publicado 2005

HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation

por Jung, C, Kim, R-S, Zhang, H, Lee, S-J, Sheng, H, Loehrer, P J, Gardner, T A, Jeng, M-H, Kao, C
Publicado 2005

Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon

por Donnelly, E T, Bardwell, H, Thomas, G A, Williams, E D, Hoper, M, Crowe, P, McCluggage, W G, Stevenson, M, Phillips, D H, Hewer, A, Osborne, M R, Campbell, F C
Publicado 2005

Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study

por Mukherjee, A, Westwell, A D, Bradshaw, T D, Stevens, M F G, Carmichael, J, Martin, S G
Publicado 2005